Sep 11, 2025 • GlobeNewswire
NEUTRAL
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology ( EADV ) 2025 Congress
SAN FRANCISCO and BOSTON, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Apogee Therapeutics, Inc., ( Nasdaq: APGE ) , a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology ( I&I ) markets, today ...
Sep 03, 2025 • Benzinga
SOMEWHAT-BULLISH
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum - Apogee Therapeutics ( NASDAQ:APGE )
SAN FRANCISCO and BOSTON, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Apogee Therapeutics, Inc., APGE, today announced that members of management will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, September 16, 2025, at 11:30 a.m. E.T.
Sep 03, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum
SAN FRANCISCO and BOSTON, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Apogee Therapeutics, Inc., ( Nasdaq: APGE ) , today announced that members of management will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, September 16, 2025, at 11:30 a.m.
Aug 11, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results
Positive 16-week data from APEX Phase 2 Part A met all primary and key secondary endpoints for APG777, a potentially best-in-class anti-IL-13 antibody, in moderate-to-severe atopic dermatitis ...
Aug 06, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. ( APGE ) : Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 152.4% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the ...
Jul 08, 2025 • Benzinga
SOMEWHAT-BULLISH
Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics ( NASDAQ:APGE ) , Blue Gold ( NASDAQ:BGL )
U.S. stocks traded mixed midway through trading, with the Dow Jones index dipping more than 150 points on Tuesday. The Dow traded down 0.35% to 44,249.09 while the NASDAQ gained 0.07% to 20,427.63. The S&P 500 also fell, dropping, 0.03% to 6,228.39. Energy shares jumped by 2.1% on Tuesday.